Estimating the optimal rate of adjuvant chemotherapy utilization for stage III colon cancer.

ABSTRACT:

Background

Identifying optimal chemotherapy utilization rates can drive improvements in quality of care. We report a benchmarking approach to estimate the optimal rate of adjuvant chemotherapy (ACT) for stage III colon cancer.

Methods

The Ontario Cancer Registry and linked treated records were used to identify ACT utilization. Monte Carlo simulation was used to estimate the proportion of ACT rate variation that could be due to chance alone. The criterion-based benchmarking approach was used to explore whether socioeconomic or system-level factors were associated with ACT. We also used the "pared-mean" approach to identify a benchmark population of hospitals with the highest ACT rates.

Results

The study population included 2801 patients; ACT was delivered to 66% (1861/

SUBMITTER: Karim S 

PROVIDER: S-EPMC6745837 | biostudies-literature | 2019 Sep

REPOSITORIES: biostudies-literature